REVEAL-CKD: Prevalence and consequences of undiagnosed chronic kidney disease - REVEAL-CKD

Study identifier:D169AR00003

ClinicalTrials.gov identifier:NCT04847531

EudraCT identifier:N/A

CTIS identifier:N/A

Study Complete

Official Title

REVEAL-CKD: A retrospective, multinational observational study to determine the prevalence and consequences of undiagnosed chronic kidney disease

Medical condition

Chronic Kidney Disease

Phase

N/A

Healthy volunteers

No

Study drug

-

Sex

All

Actual Enrollment

1006361

Study type

Observational

Age

18 Years - n/a

Date

Study Start Date: 15 Dec 2020
Primary Completion Date: 13 Nov 2023
Study Completion Date: 13 Nov 2023

Study design

Allocation: N/A
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -

Verification:

Verified 01 Apr 2024 by AstraZeneca

Sponsors

AstraZeneca

Collaborators

-

Inclusion and exclusion criteria